Hana Must SPAC 2 Asset Resilience Ratio
Hana Must SPAC 2 asset resilience ratio. Hana Must SPAC 2 (208370) has an Asset Resilience Ratio of 18.07% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Hana Must SPAC 2 liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Hana Must SPAC 2 (2015–2024)
Asset resilience ratio of Hana Must SPAC 2 from 2015 to 2024. This chart shows how Hana Must SPAC 2's Asset Resilience Ratio has changed over time. Read 208370 current and long-term liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Hana Must SPAC 2's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Hana Must SPAC 2 asset portfolio.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩12.80 Billion | 18.07% |
| Total Liquid Assets | ₩12.80 Billion | 18.07% |
Asset Resilience Insights
- Good Liquidity Position: Hana Must SPAC 2 maintains a healthy 18.07% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Hana Must SPAC 2 Industry Peers by Asset Resilience Ratio
Compare Hana Must SPAC 2's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Applied BioCode
TW:6598 |
Medical Devices | 9.75% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Cleo Diagnostics Ltd
AU:COV |
Medical Devices | 94.64% |
|
Radiant Innovation
TWO:3373 |
Medical Devices | 0.82% |
|
Impedimed Ltd
AU:IPD |
Medical Devices | 46.15% |
|
Memphasys Ltd
AU:MEM |
Medical Devices | 0.00% |
Hana Must SPAC 2 Asset Resilience Ratio by Year (2015–2024)
Hana Must SPAC 2 asset resilience ratio by year from 2015 to 2024. The table below shows the annual Asset Resilience Ratio data for Hana Must SPAC 2.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 37.15% | ₩26.09 Billion ≈ $17.68 Million |
₩70.22 Billion ≈ $47.59 Million |
+0.74pp |
| 2023-12-31 | 36.41% | ₩24.28 Billion ≈ $16.45 Million |
₩66.68 Billion ≈ $45.19 Million |
+20.76pp |
| 2022-12-31 | 15.65% | ₩7.06 Billion ≈ $4.79 Million |
₩45.11 Billion ≈ $30.57 Million |
-14.71pp |
| 2021-12-31 | 30.36% | ₩14.87 Billion ≈ $10.08 Million |
₩48.98 Billion ≈ $33.20 Million |
+0.14pp |
| 2020-12-31 | 30.22% | ₩13.64 Billion ≈ $9.24 Million |
₩45.14 Billion ≈ $30.59 Million |
+2.75pp |
| 2019-12-31 | 27.48% | ₩12.94 Billion ≈ $8.77 Million |
₩47.11 Billion ≈ $31.92 Million |
+24.01pp |
| 2018-12-31 | 3.46% | ₩1.43 Billion ≈ $968.25K |
₩41.26 Billion ≈ $27.96 Million |
-2.55pp |
| 2017-12-31 | 6.01% | ₩3.29 Billion ≈ $2.23 Million |
₩54.70 Billion ≈ $37.07 Million |
-4.36pp |
| 2016-12-31 | 10.37% | ₩4.71 Billion ≈ $3.20 Million |
₩45.48 Billion ≈ $30.82 Million |
+10.33pp |
| 2015-12-31 | 0.03% | ₩16.50 Million ≈ $11.18K |
₩47.25 Billion ≈ $32.02 Million |
-- |
About Hana Must SPAC 2
SELVAS Healthcare, Inc. operates as a medical device company in South Korea. The company provides body composition analyzers and automatic blood pressure monitors for hospitals. It also offers Braille Sense notetakers and other products for blind and visually impaired people under the HIMS brand name, as well as provides digital health products under the ACCUNIQ brand name. In addition, The compa… Read more